In general, the results not only indicate that CD103+CD8+ TRMs have an independent influence on OS in CRC patients but also suggest that if we find CD8+ TRM < 2/HPF in CRC tissues in our clinical practice, it indicates that the patient may be more likely to develop liver metastasis. This evidence concerns the gene ITGAE and colorectal carcinoma.